{
  "date": "2026-02-07 01:31:52",
  "patient": {
    "age": 64,
    "gender": "Male",
    "condition": "",
    "diagnosis": "type 2 diabetes",
    "social_risk_factors": "none",
    "date_of_assessment": "2026-02-07",
    "MedicalHistory": []
  },
  "medications": [
    "Metformin"
  ],
  "total_adrs_analyzed": 1,
  "patient_context_applied": false,
  "factor_3_4_risk_mitigation_feasibility": {
    "risk_reversibility_risk_tolerability": {
      "Metformin - Renal Failure": {
        "medicine": "Metformin",
        "adr_name": "Renal Failure",
        "adr_type": "LT/Fatal ADR",
        "classification": "Reversible ADR",
        "reasoning": "The FDA USPI mentions acute renal failure, sometimes requiring dialysis, which implies that renal function can potentially recover after discontinuation of ZITUVIMET, even if temporary dialysis is required. Therefore, this ADR is considered reversible.",
        "fda_evidence": "Acute Renal Failure: Has been reported postmarketing, sometimes requiring dialysis. Before initiating ZITUVIMET and at least annually thereafter, assess renal function.",
        "keywords_found": [
          "Acute Renal Failure",
          "dialysis"
        ]
      }
    },
    "risk_preventability": {
      "Metformin - Renal Failure": {
        "medicine": "Metformin",
        "adr_name": "Renal Failure",
        "adr_type": "LT/Fatal ADR",
        "classification": "Preventable ADR",
        "reasoning": "The FDA USPI for Metformin states that acute renal failure has been reported postmarketing, sometimes requiring dialysis and advises assessing renal function before initiating ZITUVIMET and at least annually thereafter. Therefore, renal failure as an ADR of Metformin can be potentially prevented through proactive monitoring of renal function and dose adjustments or discontinuation if necessary.",
        "fda_evidence": "Acute Renal Failure: Has been reported postmarketing, sometimes requiring dialysis. Before initiating ZITUVIMET and at least annually thereafter, assess renal function.",
        "prevention_measures": [
          "Assess renal function before initiating metformin",
          "Assess renal function at least annually",
          "Dose adjustment based on renal function",
          "Discontinuation of metformin if renal function declines significantly"
        ]
      }
    }
  },
  "mitigation_score": {
    "mitigation_sub_factor": "Preventable and Reversible ADR",
    "worst_case_adr": "Manageable",
    "description": "Preventable and Reversible ADR",
    "weight": 100,
    "score": 1,
    "weighted_score": 100,
    "score_type": "risk"
  }
}